Temple Research Finds That Tweaking CBD May Help It Curb Pain And Opioid Use In Mice

The next generation of cannabis-inspired medicine might be grown in test tubes instead of greenhouses. Researchers at Temple University have partnered with Doylestown-based pharmaceutical company Neuropathix to develop a synthetic molecule based on cannabidiol (CBD) that can provide more potent pain relief than CBD itself. They are currently studying it in a type of chronic pain caused by nerve damage due to chemotherapy. The CBD-based drug could offer an appealing alternative to addictive opioids and…

Leave a Comment

Your email address will not be published.